Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the …
ME Weinblatt, EC Keystone, DE Furst… - Arthritis & …, 2003 - Wiley Online Library
… Weinblatt has also received honoraria as a member of the scientific advisory board and as a
… Weinblatt has also received honoraria as a member of the scientific advisory board and as a …
… Weinblatt has also received honoraria as a member of the scientific advisory board and as a …
Principal components analysis corrects for stratification in genome-wide association studies
AL Price, NJ Patterson, RM Plenge, ME Weinblatt… - Nature …, 2006 - nature.com
Population stratification—allele frequency differences between cases and controls due to
systematic ancestry differences—can cause spurious associations in disease studies. We …
systematic ancestry differences—can cause spurious associations in disease studies. We …
2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis
…, S Venkatachalam, ME Weinblatt… - Arthritis & …, 2021 - Wiley Online Library
Objective To develop updated guidelines for the pharmacologic management of rheumatoid
arthritis. Methods We developed clinically relevant population, intervention, comparator, …
arthritis. Methods We developed clinically relevant population, intervention, comparator, …
Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial
…, MLM Lange, ND McDonnell, ME Weinblatt - Annals of internal …, 1999 - acpjournals.org
Background: In a phase II study, etanercept (recombinant human tumor necrosis factor
receptor [p75]:Fc fusion protein) safely produced rapid, dose-dependent improvement in …
receptor [p75]:Fc fusion protein) safely produced rapid, dose-dependent improvement in …
[HTML][HTML] A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
ME Weinblatt, JM Kremer, AD Bankhurst… - … England Journal of …, 1999 - Mass Medical Soc
Background Patients treated with methotrexate for rheumatoid arthritis often improve but
continue to have active disease. This study was undertaken to determine whether the addition …
continue to have active disease. This study was undertaken to determine whether the addition …
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
…, CE van der Schoot, PLCM van Riel, ME Weinblatt… - Nature …, 2010 - nature.com
To identify new genetic risk factors for rheumatoid arthritis, we conducted a genome-wide
association study meta-analysis of 5,539 autoantibody-positive individuals with rheumatoid …
association study meta-analysis of 5,539 autoantibody-positive individuals with rheumatoid …
Platelets amplify inflammation in arthritis via collagen-dependent microparticle production
…, ME Weinblatt, EM Massarotti, E Remold-O'Donnell… - Science, 2010 - science.org
In addition to their pivotal role in thrombosis and wound repair, platelets participate in
inflammatory responses. We investigated the role of platelets in the autoimmune disease …
inflammatory responses. We investigated the role of platelets in the autoimmune disease …
Efficacy of low-dose methotrexate in rheumatoid arthritis
ME Weinblatt, JS Coblyn, DA Fox… - … England Journal of …, 1985 - Mass Medical Soc
Twenty-eight patients with refractory rheumatoid arthritis completed a randomized 24-week
double-blind crossover trial comparing oral methotrexate (2.5 to 5 mg every 12 hours for …
double-blind crossover trial comparing oral methotrexate (2.5 to 5 mg every 12 hours for …
Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis
CD4 + T cells are central mediators of autoimmune pathology; however, defining their key
effector functions in specific autoimmune diseases remains challenging. Pathogenic CD4 + T …
effector functions in specific autoimmune diseases remains challenging. Pathogenic CD4 + T …
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: results of a twenty‐four …
…, E Hurd, J Cush, M Schiff, ME Weinblatt… - Arthritis & …, 2002 - Wiley Online Library
Objective To evaluate the efficacy and safety of anakinra in combination with methotrexate (MTX)
in patients with active rheumatoid arthritis (RA). Methods Patients with moderate‐to‐…
in patients with active rheumatoid arthritis (RA). Methods Patients with moderate‐to‐…